Clinical Trial

A Clinical Study of SPH7854 Granules in Healthy Subjects.

Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
To evaluate the safety of SPH7854 in healthy subjects.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-06-27; most recent amendment 2026-04-29.
Trial Details
NCT Number NCT06483373
Lead Sponsor Shanghai Pharmaceuticals Holding Co., Ltd
Conditions Inflammatory Bowel Disease
Enrollment 111 participants
Start Date 2024-05-28
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-05